These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 16005563)

  • 1. Risk factors for mucosal prostatic urethral involvement in superficial transitional cell carcinoma of the bladder.
    Mungan MU; Canda AE; Tuzel E; Yorukoglu K; Kirkali Z
    Eur Urol; 2005 Nov; 48(5):760-3. PubMed ID: 16005563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conservative management of mucosal prostatic urethral involvement in patients with superficial transitional cell carcinoma of the bladder.
    Canda AE; Tuzel E; Mungan MU; Yorukoglu K; Kirkali Z
    Eur Urol; 2004 Apr; 45(4):465-9; discussion 469-70. PubMed ID: 15041110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients.
    Stein JP; Clark P; Miranda G; Cai J; Groshen S; Skinner DG
    J Urol; 2005 Apr; 173(4):1163-8. PubMed ID: 15758728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance.
    Shen SS; Lerner SP; Muezzinoglu B; Truong LD; Amiel G; Wheeler TM
    Hum Pathol; 2006 Jun; 37(6):726-34. PubMed ID: 16733214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology.
    Raman JD; Ng CK; Boorjian SA; Vaughan ED; Sosa RE; Scherr DS
    BJU Int; 2005 Nov; 96(7):1031-5. PubMed ID: 16225523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study of transitional cell carcinoma in the prostatic urethra and prostate in the cystoprostatectomy specimen. Incidence, characteristics and preoperative detection.
    Liedberg F; Anderson H; Bläckberg M; Chebil G; Davidsson T; Gudjonsson S; Jahnson S; Olsson H; Månsson W
    Scand J Urol Nephrol; 2007; 41(4):290-6. PubMed ID: 17763219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superficial urothelial cancer in the prostatic urethra.
    Kirkali Z; Canda AE
    ScientificWorldJournal; 2006 Feb; 6():2603-10. PubMed ID: 17619737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transitional cell carcinoma of the prostate in cystoprostatectomy specimens].
    Liedberg F; Chebil G; Davidsson T; Malmström PU; Sherif A; Månsson W
    Aktuelle Urol; 2003 Sep; 34(5):333-6. PubMed ID: 14566661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for urothelial carcinoma of the prostate in patients undergoing radical cystoprostatectomy for bladder cancer.
    Patel SG; Cookson MS; Barocas DA; Clark PE; Smith JA; Chang SS
    BJU Int; 2009 Oct; 104(7):934-7. PubMed ID: 19338554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ.
    Sakai I; Miyake H; Harada K; Hara I; Inoue TA; Fujisawa M
    Int J Urol; 2006 Nov; 13(11):1389-92. PubMed ID: 17083389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk factor for urethral recurrence after radical cystectomy in patients with transitional cell carcinoma of the bladder.
    Cho KS; Seo JW; Park SJ; Lee YH; Choi YD; Cho NH; Yang SC; Hong SJ
    Urol Int; 2009; 82(3):306-11. PubMed ID: 19440019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy.
    Shariat SF; Palapattu GS; Karakiewicz PI; Rogers CG; Vazina A; Bastian PJ; Schoenberg MP; Lerner SP; Sagalowsky AI; Lotan Y
    Eur Urol; 2007 Jan; 51(1):152-60. PubMed ID: 17011114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Membranous and penile urethral involvement in bladder cancer patients-- review of cystoprostatourethrectomy specimens].
    Shimizu T; Suzuki T; Yamanaka H; Satoh J; Suzuki K
    Hinyokika Kiyo; 1994 Oct; 40(10):869-72. PubMed ID: 7992699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
    Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
    J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upper tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: incidence and risk factors.
    Sved PD; Gomez P; Nieder AM; Manoharan M; Kim SS; Soloway MS
    BJU Int; 2004 Oct; 94(6):785-9. PubMed ID: 15476508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate stem cell antigen predicts tumour recurrence in superficial transitional cell carcinoma of the urinary bladder.
    Elsamman E; Fukumori T; Kasai T; Nakatsuji H; Nishitani MA; Toida K; Ali N; Kanayama HO
    BJU Int; 2006 Jun; 97(6):1202-7. PubMed ID: 16686711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
    Yang TB; Zeng FH; Sun ZQ
    Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk assessment for occult malignancy in the prostate before radical cystectomy.
    Kefer JC; Voelzke BB; Flanigan RC; Wojcik EM; Waters WB; Campbell SC
    Urology; 2005 Dec; 66(6):1251-5. PubMed ID: 16360452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing selection criteria for prostate-sparing cystectomy: a review of cystoprostatectomy specimens.
    Richards KA; Parks GE; Badlani GH; Kader AK; Hemal AK; Pettus JA
    Urology; 2010 May; 75(5):1116-20. PubMed ID: 20080289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of urethral, vaginal and cervical involvement in patients undergoing radical cystectomy for bladder cancer: results of a contemporary cystectomy series from M. D. Anderson Cancer Center.
    Chen ME; Pisters LL; Malpica A; Pettaway CA; Dinney CP
    J Urol; 1997 Jun; 157(6):2120-3. PubMed ID: 9146596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.